Nurix Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| NRIX | KYMR | 3378.HK | GLUE | BINV.ST | BHVN | |
|---|---|---|---|---|---|---|
| Market cap | 1.74B | 11.63B | 3.73B | 923.09M | 234.92M | 2.30B |
| P/E (TTM) | 6.6 | — | — | — | — | — |
| Forward P/E | -12.5 | -27.1 | — | -5.9 | -0.9 | -8.2 |
| Price/book | 1.8 | 7.2 | 5.1 | 1.9 | 1.2 | -23.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +107.31% | +112.21% | +54.07% | −15.43% | −88.59% | +87.17% |
| Today | −38.23% | +7.21% | +5.13% | +3.94% | −0.42% | −2.37% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All NRIX news ›Why NurExone Biologic (TSXV:NRX) Is in Focus After Consistent Exosome Batch Data?
Consistency between batches is a known challenge in exosome therapeutics. Reproducible activity is important for regulators and manufacturing partners. Canadian healthcare and life sciences companies continue developing therapies, devices…
NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update
As part of the Company’s business development and stakeholder-engagement activities in the U.S., Chief Executive Officer Dr. Lior Shaltiel will actively participate as speaker in three conference programs and attend the invitation-only…
NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results
TORONTO and HAIFA, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone ” or the “... NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results TORONTO and HAIFA,…
NurExone Demonstrates Consistent Anti-Inflammatory Activity Across Three Separate Batches of Exosomes
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) today announced new laboratory results demonstrating consistent anti-inflammatory activity across three ... NurExone Demonstrates Consistent…
NurExone Biologic Demonstrates Scalable Exosome Production With Two Bioreactors
NurExone Biologic (NRX.V,NRXBF) announced that it doubled exosome production by operating two bioreactors in parallel without increasing overall manufacturing time. The process maintained consistency and comparable exosome quality, marking…
NurExone Reports Up To 88% Reduction In Inflammatory Marker In Exosome Study
In laboratory testing, all three batches showed dose-dependent reductions in the inflammatory proteins IL-6 and TNF-a. At the highest tested concentration, average levels declined by approximately 88% and 57%, respectively, compared with…
NurExone Biologic Inc. announced that it has received CAD 1.066079 million in funding
NurExone Biologic Inc announced that it has completed non-brokered private placement of 1,938,326 units at the price of CAD 0.55 per share for the proceeds of CAD 1,066,078.02 on August 20, 2026. Each... Biotechnology & Medical Research…
NurExone Biologic Inc. Announces Board Changes
NurExone Biologic Inc. announced the appointment of Mr. David Stolick to its Board of Directors, effective July 28, 2026. Mr. Stolick succeeded the late James Jay Richardson, whose leadership helped... Published on 07/28/2026 at 05:24 pm…
NurExone Biologic Inc. and Exolyra Llc Enter into Binding Memorandum of Understanding for Naïve Exosome Distribution in Mexico
NurExone Biologic Inc. announced that its wholly owned U.S. subsidiary, Exo-Top Inc., has entered into a binding memorandum of understanding setting out the principal commercial terms for a proposed... Biotechnology & Medical Research…
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
Apr 16, 2024, 18:30 ET Bob Dagher, MD, Promoted to Chief Medical Officer Dr. Stacy Lindborg Stepping Down as Co-CEO and Transitioning to Board of Directors Mr. Lebovits concluded, "I would like to thank Stacy for her outstanding commitment…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com6
- stocktitan.net5
- markets.businessinsider.com4
- themarketsdaily.com3
- tradingview.com3
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 39 articles, not a forecast.